Lantheus Holdings (LNTH) Operating Margin (2014 - 2026)
Lantheus Holdings (LNTH) reported Operating Margin of 21.55% for Q1 2026, down 583.0% year-over-year from 4.46% in Q1 2025, and up 13.59% quarter-over-quarter from 18.97% in Q4 2025.
Lantheus Holdings (LNTH) Operating Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Operating Margin data on file, last reported at 21.55% in Q1 2026.
- Operating Margin for Q1 2026 came in at 21.55%, down 583.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.76% (up 1317.0% YoY), and the FY2025 annual result was 20.16%, up 1426.0% from the prior year.
- Operating Margin improved to 21.55% in Q1 2026 per LNTH's latest filing, from 18.97% in the prior quarter.
- Over five years, Operating Margin peaked at 38.59% in Q2 2023 and troughed at 939.05% in Q4 2023.
- A 5-year average of 41.96% and a median of 26.07% in 2024 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2023 and 2024: Operating Margin plunged 87382 bps in 2023, then surged 87447 bps in 2024.
- A 5-year view of Operating Margin shows it stood at 65.24% in 2022, then sank by 1339 bps to 939.05% in 2023, then jumped by 93 bps to 64.59% in 2024, then surged by 129 bps to 18.97% in 2025, then increased by 14 bps to 21.55% in 2026.
- Business Quant data shows LNTH's Operating Margin at 21.55% in Q1 2026, 18.97% in Q4 2025, and 11.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.55% |
| Dec 31, 2025 | 18.97% |
| Sep 30, 2025 | 11.36% |
| Jun 30, 2025 | 23.27% |
| Mar 31, 2025 | 27.38% |
| Dec 31, 2024 | -64.59% |
| Sep 30, 2024 | 35.31% |
| Jun 30, 2024 | 26.07% |
| Mar 31, 2024 | 28.82% |
| Dec 31, 2023 | -939.05% |
| Sep 30, 2023 | 35.12% |
| Jun 30, 2023 | 38.59% |
| Mar 31, 2023 | -3.11% |
| Dec 31, 2022 | -65.24% |
| Sep 30, 2022 | 35.83% |
| Jun 30, 2022 | 28.25% |
| Mar 31, 2022 | 28.21% |
| Dec 31, 2021 | -27.27% |
| Sep 30, 2021 | -14.04% |
| Jun 30, 2021 | -26.50% |